← All Ptc Therapeutics, INC filings

Ptc Therapeutics, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
PTCT
Ptc Therapeutics, INC
DEF: PTC Therapeutics 2026 Annual Meeting Proxy Statement
PTC Therapeutics, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation advisory vote.
NASDAQ
PTCT
Ptc Therapeutics, INC
DEFA14A: PTC Therapeutics Sets Date for 2025 Annual Meeting, Outlines Voting Procedures
PTC Therapeutics announces its 2025 Annual Meeting to be held virtually on June 17, 2025, and provides details on how stockholders can vote on key proposals.
NASDAQ
PTCT
Ptc Therapeutics, INC
DEF 14A: PTC Therapeutics Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals
PTC Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on June 17, 2025, featuring director elections, auditor ratification, and executive compensation advisory vote.
NASDAQ
PTCT
Ptc Therapeutics, INC
DEFA14A: PTC Therapeutics Sets Date for 2024 Annual Meeting, Outlines Voting Matters
PTC Therapeutics announces its 2024 Annual Meeting to be held virtually on June 18, 2024, outlining key voting items for shareholders.
NASDAQ
PTCT
Ptc Therapeutics, INC
DEF 14A: PTC Therapeutics Announces 2024 Annual Meeting of Stockholders
PTC Therapeutics will hold its 2024 Annual Meeting of Stockholders virtually on June 18, 2024, to vote on director elections, auditor ratification, and executive compensation.